Medicare Enrolled
Dr. Po Lam, MD
Urology Physician · Syracuse, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lam?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lam
Dr. Po Lam is an urology physician in Syracuse, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lam performed 5,909 Medicare services across 1,510 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lam received a total of $32,272 from 50 pharmaceutical and/or device companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 15% volume in NY
$32,272 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,909
Medicare services
Top 15% in NY for urology physician
1,510
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~295 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,900 | $0 | $2 |
| BCG treatment for bladder cancer | 1,100 | $2 | $6 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
445 | $2 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
254 | $86 | $262 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
218 | $59 | $179 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
138 | $49 | $124 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
106 | $47 | $123 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
92 | $21 | $130 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
81 | $8 | $11 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
80 | $56 | $184 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
71 | $126 | $354 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
66 | $177 | $718 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
58 | $7 | $45 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
49 | $876 | $3,604 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
44 | $35 | $94 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
30 | $97 | $267 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
25 | $38 | $109 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
24 | $72 | $271 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $95 | $383 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
23 | $68 | $215 |
| Endoscopic removal of pelvic lymph nodes, bilateral A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue. |
22 | $245 | $1,663 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
20 | $202 | $675 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
16 | $48 | $148 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
12 | $65 | $183 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
11 | $19 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$32,272
Total received (2018-2024)
Avg $4,610/year across 7 years
Top 8% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
174
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,869 (49.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,237 (28.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,166 (22.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,440
2023
$14,849
2022
$4,801
2021
$559
2020
$354
2019
$1,309
2018
$1,960
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UROGEN PHARMA, INC.
$2,091
AstraZeneca Pharmaceuticals LP
$1,458
INTUITIVE SURGICAL, INC.
$1,200
Telix Pharmaceuticals
$907
Janssen Biotech, Inc.
$805
Dendreon Pharmaceuticals LLC
$291
Myriad Genetic Laboratories, Inc.
$249
Teleflex LLC
$220
IMMUNITYBIO, INC.
$215
COLOPLAST CORP
$173
Tolmar, Inc.
$151
Astellas Pharma US Inc
$131
PROGENICS PHARMACEUTICALS, INC.
$122
Merck Sharp & Dohme LLC
$119
Sumitomo Pharma America, Inc.
$80
Novartis Pharmaceuticals Corporation
$60
Ferring Pharmaceuticals Inc.
$52
Cardinal Health 108 LLC
$45
Janssen Scientific Affairs, LLC
$31
ACCORD HEALTHCARE, INC.
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
Top 3 companies account for 56.3% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$13,006
Ferring Pharmaceuticals Inc.
$3,807
AstraZeneca Pharmaceuticals LP
$2,949
UROGEN PHARMA, INC.
$2,091
INTUITIVE SURGICAL, INC.
$1,200
Merck Sharp & Dohme Corporation
$1,035
Janssen Biotech, Inc.
$987
Telix Pharmaceuticals
$907
Dendreon Pharmaceuticals LLC
$659
Bayer HealthCare Pharmaceuticals Inc.
$643
CONMED Corporation
$574
Endocare, Inc.
$505
NeoTract Inc.
$442
Teleflex LLC
$362
Myriad Genetic Laboratories, Inc.
$328
Astellas Pharma US Inc
$261
Palette Life Sciences, Inc.
$226
IMMUNITYBIO, INC.
$215
Merck Sharp & Dohme LLC
$200
COLOPLAST CORP
$173
Tolmar, Inc.
$151
Davol Inc.
$146
Coloplast Corp
$145
Olympus America Inc.
$128
Sumitomo Pharma America, Inc.
$122
PROGENICS PHARMACEUTICALS, INC.
$122
UroGen Pharma, Inc.
$107
Janssen Scientific Affairs, LLC
$105
EISAI INC.
$100
C. R. BARD, INC. & SUBSIDIARIES
$98
Novartis Pharmaceuticals Corporation
$60
Cardinal Health 108 LLC
$45
Bayer Healthcare Pharmaceuticals Inc.
$43
Ethicon US, LLC
$40
PFIZER INC.
$40
Progenics Pharmaceuticals, Inc.
$24
Agiliti Surgical, Inc.
$22
ACCORD HEALTHCARE, INC.
$20
Amgen Inc.
$19
ABBVIE INC.
$19
Antares Pharma, Inc.
$18
Myovant Sciences Inc.
$17
AbbVie Inc.
$17
AbbVie, Inc.
$15
Mission Pharmacal Company
$14
Otsuka America Pharmaceutical, Inc.
$14
180 Medical, Inc.
$13
Endo Pharmaceuticals Inc.
$13
TOLMAR Pharmaceuticals, Inc.
$12
HealthTronics Mobile Solutions, LLC
$11
Top 3 companies account for 61.2% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AIRSEAL · ANKTIVA · BOTOX · CAMCEVI · Coloplast TFL Drive · DA VINCI SP · Da Vinci Surgical System · ELIGARD · ERLEADA · Endocare Cryocare System · Erleada · GentleCath · ILLUCCIX · IMFINZI · JELMYTO · JYNARQUE · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lenvima · Lupron Depot · MYRBETRIQ · Myrbetriq · Nubeqa · ORGOVYX · OTREXUP · Olympus Laser Devices · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Phasix Mesh · Prolaris · SUTENT · Sonablate · UROLIFT · UroLift · Urocit-K · VISTASEAL · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (49%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for urology physician in NY.
Geographic Context
Urology physicians within 10 mi
61
Per 100K population
12.9
County median income
$74,740
Nearest hospital
CROUSE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lam is a mixed practice specialist, with above-average Medicare volume (top 15% in NY), with speaking/promotional industry engagement in the top 8% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lam experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Lam performed 2,900 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lam receive payments from pharmaceutical companies?
Yes. Dr. Lam received a total of $32,272 from 50 companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lam's costs compare to other urology physicians in Syracuse?
Dr. Lam's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Syracuse
Browse urology physicians in Syracuse ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
Ferring Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Ferring Pharmaceuticals Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology